The effect of anthracycline-based chemotherapy on endothelial function and arterial stiffness in breast cancer patients

被引：0
|
作者：
Anastasiou, M. [1 ]
Oikonomou, E. [2 ]
Theofilis, P. [3 ]
Papamikroulis, G. A. [2 ]
Gazouli, M. [4 ]
Pesiridis, T. [2 ]
Goliopoulou, A. [2 ]
Papatheodoridi, D. [5 ]
Psyrri, A. [1 ]
Zagouri, F. [5 ]
Siasos, G. [2 ]
Tousoulis, D. [3 ]
机构：
[1] Attikon Univ Hosp, Athens, Greece
[2] Sotiria Reg Chest Dis Hosp, Dept Cardiol 3, Athens, Greece
[3] Hippokrateion Hosp, Athens, Greece
[4] Univ Athens, Sch Med, Athens, Greece
[5] Alexandra Univ Hosp, Athens, Greece
来源：
EUROPEAN HEART JOURNAL | 2023年 / 44卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Right heart function deteriorates in breast cancer patients undergoing anthracycline-based chemotherapy
    Boczar K.E.
    Aseyev O.
    Sulpher J.
    Johnson C.
    Burwash I.G.
    Turek M.
    Dent S.
    Dwivedi G.
    Echo Research & Practice, 2016, 3 (3): : 79 - 84
  • [2] Effect of Eplerenone on Diastolic Function in Women Receiving Anthracycline-Based Chemotherapy for Breast Cancer
    Davis, Margot K.
    Villa, Diego
    Tsang, Teresa S. M.
    Starovoytov, Andrew
    Gelmon, Karen
    Virani, Sean A.
    JACC: CARDIOONCOLOGY, 2019, 1 (02): : 295 - 298
  • [3] Anthracycline-based adjuvant chemotherapy in breast cancer
    Gray, Richard
    LANCET, 2010, 375 (9729): : 1870 - 1871
  • [4] Left ventricular diastolic function in patients with breast cancer treated with anthracycline-based chemotherapy
    Mincu, R.
    Lampe, L.
    Rassaf, T.
    Totzeck, M.
    EUROPEAN HEART JOURNAL, 2021, 42 : 2843 - 2843
  • [5] Cardioprotective effect of Trimetazidine in patients with early breast cancer receiving anthracycline-based chemotherapy
    Delle Donne, M. G.
    Iannielli, A.
    Capozza, P.
    De Caterina, R.
    Marzilli, M.
    EUROPEAN HEART JOURNAL, 2020, 41 : 880 - 880
  • [6] Optimum anthracycline-based chemotherapy for early breast cancer
    Adlard, Julian W.
    Dodwell, David J.
    LANCET ONCOLOGY, 2001, 2 (08): : 469 - 474
  • [7] Docetaxel and anthracycline-based neoadjuvant chemotherapy in breast cancer
    Tiezzi, D. G.
    Andrade, J. M.
    Macchetti, A. H.
    Clagnan, W. S.
    Marana, H. R.
    Zola, F. E.
    Peria, F. M.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [8] Late-onset cardiotoxicity in Anthracycline-based chemotherapy for breast cancer patients
    Mata Caballero, R.
    Serrano Antolin, J. M.
    Gonzalez Garcia, I. A.
    Muniz Garcia, J.
    Curcio Ruigomez, A.
    Gutierrez Landaluce, C.
    Morales Garcia, L. J.
    Del Castillo Arrojo, S.
    Guerra Martinez, J. A.
    Graupner Abad, C.
    Jimenez Hernandez, R. M.
    Cristobal Varela, C.
    Malon Gimenez, D.
    Talavera Calle, P.
    Alonso Martin, J. J.
    EUROPEAN HEART JOURNAL, 2016, 37 : 118 - 119
  • [9] Oxidative and antioxidative status after anthracycline-based chemotherapy in breast cancer patients
    Alacacioglu, A.
    Kebapcilar, L.
    Pamuk, B. Onder
    Sop, G.
    Kucukiravul, C.
    Bozkaya, G.
    Yuksel, A.
    Alacacioglu, I.
    Sari, I.
    JOURNAL OF BUON, 2013, 18 (03): : 614 - 618
  • [10] Predictors of inflammation in response to anthracycline-based chemotherapy for breast cancer
    Mills, Paul J.
    Ancoli-Israel, Sonia
    Parker, Barbara
    Natarajan, Loki
    Hong, Suzi
    Jain, Shamini
    Sadler, Georgia R.
    von Kaenel, Roland
    BRAIN BEHAVIOR AND IMMUNITY, 2008, 22 (01) : 98 - 104
12345